Wolverine Trading
XBI icon

Wolverine Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wolverine Trading’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.16M Sell
61,981
-11,862
-16% -$1.07M ﹤0.01% 1232
2025
Q2 		$6.13M Buy
73,843
+70,243
+1,951% +$5.6M 0.01% 942
2025
Q1 		$304K Sell
3,600
-52,903
-94% -$4.73M ﹤0.01% 3509
2024
Q4 		$5.08M Buy
56,503
+42,297
+298% +$4.1M ﹤0.01% 1196
2024
Q3 		$1.4M Sell
14,206
-3,325
-19% -$327K ﹤0.01% 2033
2024
Q2 		$1.63M Buy
17,531
+663
+4% +$59.4K ﹤0.01% 1754
2024
Q1 		$1.6M Sell
16,868
-16,398
-49% -$1.52M ﹤0.01% 1777
2023
Q4 		$2.97M Sell
33,266
-27,485
-45% -$2.04M ﹤0.01% 1413
2023
Q3 		$4.44M Buy
+60,751
New +$4.85M ﹤0.01% 1084
2023
Q2 		– Sell
-180,837
Closed -$13.5M – 5068
2023
Q1 		$13.5M Buy
180,837
+84,671
+88% +$7.03M 0.02% 439
2022
Q4 		$7.98M Sell
96,166
-11,708
-11% -$948K 0.01% 691
2022
Q3 		$8.51M Sell
107,874
-30,617
-22% -$2.58M 0.01% 625
2022
Q2 		$10.4M Buy
138,491
+40,262
+41% +$3.02M 0.02% 501
2022
Q1 		$8.91M Sell
98,229
-61,587
-39% -$5.69M 0.01% 748
2021
Q4 		$18.1M Buy
159,816
+93,503
+141% +$11.3M 0.02% 496
2021
Q3 		$8.33M Buy
66,313
+32,306
+95% +$4.16M 0.01% 929
2021
Q2 		$4.62M Sell
34,007
-33,726
-50% -$4.43M 0.01% 1206
2021
Q1 		$8.81M Buy
67,733
+31,702
+88% +$4.75M 0.01% 758
2020
Q4 		$5.19M Buy
+36,031
New +$4.61M 0.01% 1034
2020
Q3 		– Sell
-38,654
Closed -$4.27M – 5270
2020
Q2 		$4.27M Buy
38,654
+15,130
+64% +$1.49M 0.01% 902
2020
Q1 		$1.84M Buy
23,524
+5,032
+27% +$446K 0.01% 1418
2019
Q4 		$1.75M Buy
+18,492
New +$1.6M ﹤0.01% 1941
2019
Q3 		– Sell
-23,073
Closed -$2.02M – 5129
2019
Q2 		$2.02M Buy
23,073
+16,304
+241% +$1.39M 0.01% 1483
2019
Q1 		$613K Sell
6,769
-89,831
-93% -$7.64M ﹤0.01% 2550
2018
Q4 		$6.77M Buy
96,600
+89,511
+1,263% +$7.21M 0.02% 634
2018
Q3 		$680K Sell
7,089
-7,514
-51% -$729K ﹤0.01% 2753
2018
Q2 		$1.28M Hold
14,603
– – ﹤0.01% 2002
2018
Q1 		$1.28M Sell
14,603
-16,797
-53% -$1.53M ﹤0.01% 2002
2017
Q4 		$2.67M Buy
31,400
+10,701
+52% +$896K 0.01% 1305
2017
Q3 		$1.79M Buy
20,699
+16,947
+452% +$1.36M 0.01% 1413
2017
Q2 		$293K Sell
3,752
-8,959
-70% -$635K ﹤0.01% 3077
2017
Q1 		$880K Sell
12,711
-15,149
-54% -$1.02M ﹤0.01% 1828
2016
Q4 		$1.65M Sell
27,860
-48,386
-63% -$2.99M 0.01% 1485
2016
Q3 		$5M Buy
76,246
+2,747
+4% +$170K 0.02% 751
2016
Q2 		$3.97M Buy
+73,499
New +$4.03M 0.02% 713

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wolverine Trading's XBI Position: Q3 2025 in Review

Wolverine Trading reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 16% in Q3 2025, selling an estimated $1.07M and leaving 61,981 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1232.

Wolverine Trading first reported a position in XBI in Q2 2016 and has held it in 35 quarters since. The position peaked at $18.1M in Q4 2021. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Wolverine Trading held 61,981 shares of State Street SPDR S&P Biotech ETF worth $6.16M as of Q3 2025.
  • Wolverine Trading sold 11,862 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.07M.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1232 holding.
  • Wolverine Trading first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 35 quarters since.
  • Wolverine Trading's State Street SPDR S&P Biotech ETF position peaked at $18.1M in Q4 2021.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.